Choice of antithrombotic agent in ACS: REACT-ing to recent trials.

Back

Open Access

Choice of antithrombotic agent in ACS: REACT-ing to recent trials.

Session: Navigating the Antithrombotic Maze: What to do for Your ACS Patients in the Era of Contemporary PCI

Topic: Pharmacotherapy

Speaker: Professor S. James (Uppsala, SE)

Organised by Radcliffe Cardiology, supported by AstraZeneca in the form of an educational grant

Event: ESC Congress 2020

Congress Presentation

About the speaker

Professor Stefan James

Uppsala University, Uppsala (Sweden)

45 presentations

2 followers

5 more presentations in this session

Welcome.

Speaker: Professor K. Huber (Vienna, AT)

Access

Video

Pre-treatment in NSTE-ACS – dead or alive?

Speaker: Professor D. Capodanno (Catania, IT)

Access

Video

When to leave aspirin behind?

Speaker: Professor R. Mehran (New York, US)

Access

Video

Q&A.

Speaker: Professor K. Huber (Vienna, AT) Professor D. Capodanno (Catania, IT) Professor S. James (Uppsala, SE) Professor R. Mehran (New York, US)

Access

Video

Summary and close.

Speaker: Professor K. Huber (Vienna, AT)

Access

Video

Access the full session

Navigating the Antithrombotic Maze: What to do for Your ACS Patients in the Era of Contemporary PCI

Speakers: Professor S. James, Professor K. Huber, Professor D. Capodanno, Professor R. Mehran, Professor K. Huber...

Access

Video

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

Choice of antithrombotic agent in ACS: REACT-ing to recent trials.

About the speaker

Professor Stefan James

5 more presentations in this session

Welcome.

Pre-treatment in NSTE-ACS – dead or alive?

When to leave aspirin behind?

Q&A.

Summary and close.

Access the full session

Navigating the Antithrombotic Maze: What to do for Your ACS Patients in the Era of Contemporary PCI

About the event

ESC Congress 2020

ESC 365 is supported by